Enhancing Precision Oncology : Preclinical Assessment of Individual Drug Treatment Susceptibility Using Patient-Derived 3D Microtumor and Immune Cell Co-cultures
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Tübingen, Universität Tübingen, Dissertation, 2024
- Klassifikation
-
Naturwissenschaften
Biowissenschaften, Biologie
Medizin, Gesundheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Tübingen
- (wer)
-
Universitätsbibliothek Tübingen
- (wann)
-
2024
- Urheber
- Beteiligte Personen und Organisationen
-
Schenke-Layland, Katja
- URN
-
urn:nbn:de:bsz:21-dspace-1530066
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Anderle, Nicole
- Schenke-Layland, Katja
- Universitätsbibliothek Tübingen
Entstanden
- 2024
Ähnliche Objekte (12)
Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology
Patient-derived xenografts as compatible models for precision oncology
Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
Correction: Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
Patient-derived xenografts as preclinical neuroblastoma models
Preclinical models in radiation oncology
Quo vadis precision oncology?
Patient‐Derived Microphysiological Systems for Precision Medicine
Use of patient-derived explants as a preclinical model for precision medicine in colorectal cancer: A scoping review
Precision medicine in pediatric oncology
Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM
Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology
Patient-derived xenografts as compatible models for precision oncology
Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
Correction: Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
Patient-derived xenografts as preclinical neuroblastoma models
Preclinical models in radiation oncology
Quo vadis precision oncology?
Patient‐Derived Microphysiological Systems for Precision Medicine
Use of patient-derived explants as a preclinical model for precision medicine in colorectal cancer: A scoping review
Precision medicine in pediatric oncology
Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM
Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology
Patient-derived xenografts as compatible models for precision oncology
Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
Correction: Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
Patient-derived xenografts as preclinical neuroblastoma models
Preclinical models in radiation oncology
Quo vadis precision oncology?
Patient‐Derived Microphysiological Systems for Precision Medicine
Use of patient-derived explants as a preclinical model for precision medicine in colorectal cancer: A scoping review
Precision medicine in pediatric oncology
Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology